~1 in 2 patients do not receive antibiotics within the recommended timeline, risking lives
Better cancer care
Neutropenic sepsis (NS) is the most fatal side-effect of chemotherapy treatment.
The current pathway for all patients is stressful, costly and risks lives. It requires all patients on chemotherapy who feel unwell to go straight into A&E, just in case they have NS.
There are two critical problems with this pathway:
~1 in 2 patients were never at risk of NS, and may not have needed to come into A&E
Neutrocheck® is a low-cost finger prick blood test and digital platform that provides a rapid and reliable result at home, helping doctors to identify patients at risk of neutropenic sepsis.
Get in touch to find out more.
Neutrocheck® reinvents the care pathway, making it safer and more effective.
As featured in
